CARB-X injects up to $48 million to accelerate first Powered by CARB-X projects
(WASHINGTON, D.C./ LONDON, U.K.) - The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X, announced today it is investing US$24 million immediately and up to...








